Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633965 · ClinicalTrials.gov registry record · NA
Safety and Feasibility Testing of a Smaller Network Version of AIDANET
A NA study, sponsored by Marc Breton.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT06633965 is a NA study that has completed, run by Marc Breton. The registered enrollment target is 8 participants.
The verdict
NCT06633965, a NA study, has completed, sponsored by Marc Breton.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A randomized 1:1 crossover trial that intends to demonstrate feasibility and safety of the Automated Insulin Delivery as Adaptive NETwork (AIDANET) system run in a new smaller network version, used in full closed loop (FCL) by adults who have been diagnosed with type 1 diabetes (T1D).
Interventions
- DEVICE AIDANET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-11-20 |
| Est. Completion | 2024-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06633965
The ClinicalTrials.gov registry entry for NCT06633965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marc Breton, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AIDANET is the first listed.
NCT06633965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06633965 about?
NCT06633965 is a clinical study titled "Safety and Feasibility Testing of a Smaller Network Version of AIDANET". A randomized 1:1 crossover trial that intends to demonstrate feasibility and safety of the Automated Insulin Delivery as Adaptive NETwork (AIDANET) system run in a new smaller network version, used in full closed loop (FCL) by adults who have been diagnosed with type 1 diabetes (T1D).
What is the current status of trial NCT06633965?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2024-11-20. Estimated completion is 2024-12-18.
What interventions are being tested in trial NCT06633965?
The interventions under investigation include: AIDANET (DEVICE).
Who is sponsoring clinical trial NCT06633965?
This trial is sponsored by Marc Breton, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.